EIF3H and cancer: Through multiomic analysis and experimental validation, a dysfunctional Eukaryotic Translation Initiation Factor 3 Subunit H (EIF3H)/Yes‐associated protein (YAP) proteolytic axis is identified as a pivotal junction mediating the interplay between cancer‐associated adipocytes and the response to anti‐cancer drugs in TNBC.